Antibiotics and experimental toxoplasmosis; polymyxin B-sulfate, bacitracin, terramycin, aureomycin and sulfa in experimental toxoplasmosis.
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D000904:Antibiotics, Antitubercular; D001414:Bacitracin / Q000494:pharmacology*; D002751:Chlortetracycline / Q000494:pharmacology*; D003879:Dermatologic Agents; D010118:Oxytetracycline / Q000494:pharmacology*; D011112:Polymyxin B; D000077145:Sulfanilamide; D013424:Sulfanilamides; D013431:Sulfates; D013449:Sulfonamides / Q000494:pharmacology*; D014123:Toxoplasmosis
D000900:Anti-Bacterial Agents; D000904:Antibiotics, Antitubercular; D003879:Dermatologic Agents; D013424:Sulfanilamides; D013431:Sulfates; D013449:Sulfonamides; D001414:Bacitracin; D000077145:Sulfanilamide; D011112:Polymyxin B; D002751:Chlortetracycline; D010118:Oxytetracycline
ANTIBIOTICS/effects; BACITRACIN/effects; CHLORTETRACYCLINE/effects; OXYTETRACYCLINE/effects; SULFONAMIDES/effects; TOXOPLASMOSIS/experimental